Loading...
Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A/VEGF signaling pathway and down-regulation of MDR-1 and P-gp expression in gastric cancer
The effect of 5-fluorouracil (5-FU) chemotherapy for gastric cancer (GC) is limited by drug-resistance. To conquer this drug-resistance, various treatments including combination therapy have been used, but the overall survival has not been improved yet. In our current study, 5-FU resistant GC cells,...
Saved in:
Published in: | Oncotarget |
---|---|
Main Authors: | , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
Impact Journals LLC
2017
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5669933/ https://ncbi.nlm.nih.gov/pubmed/29137307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.20666 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|